case_images: PMC10960974_01
case_images: Right lower extremity wound.. Left: Prior to treatment with Baricitinib. Right: Completion of 17 days of Baricitinib.
case_images: 10.1177_2050313X241235444-fig1.jpg
case_images: PMC10960974_01_10.1177_2050313X241235444-fig1.jpg
case_images: fig1-2050313X241235444
case_images: This ulcer was painful and continued to increase in size (Figure A1). Physical examination showed an unstageable ulcer covered by necrotic tissue involving the medial aspect of the right lower leg, ankle, and foot (Figure A1). During this time, the right lower extremity ulcer decreased in size (Figures A1 and A2).
case_images: Right lower extremity wound.. Left: Right: Completion of 5 weeks of Baricitinib. Right: 4 weeks after discontinuing Baricitinib (12 weeks completed).
case_images: 10.1177_2050313X241235444-fig2.jpg
case_images: PMC10960974_01_10.1177_2050313X241235444-fig2.jpg
case_images: fig2-2050313X241235444
case_images: During this time, the right lower extremity ulcer decreased in size (Figures A1 and A2). The ulcer on the right lower extremity had recurred (Figures A2 and A3).
case_images: Right lower extremity wound.. Left, Right: 13 weeks after discontinuing Baricitinib.
case_images: 10.1177_2050313X241235444-fig3.jpg
case_images: PMC10960974_01_10.1177_2050313X241235444-fig3.jpg
case_images: fig3-2050313X241235444
case_images: The ulcer on the right lower extremity had recurred (Figures A2 and A3). The right lower extremity ulcer further progressed (Figure A3).
case_images: Right elbow.. Left: Prior to treatment with Baricitinib. Right: Completion of 3 weeks of Baricitinib.
case_images: 10.1177_2050313X241235444-fig4.jpg
case_images: PMC10960974_01_10.1177_2050313X241235444-fig4.jpg
case_images: fig4-2050313X241235444
case_images: Moreover, the ulcers on her right axilla (Figure A6) and right elbow (Figure A4) had also increased in size over this time, and demonstrated perilesional erythema. The ulcers on the right axilla (Figure A6) and right elbow (Figure A4) resolved.
case_images: Right elbow.. Left: 4 weeks after discontinuing Baricitinib (12 weeks completed). Right: 13 weeks after discontinuing Baricitinib.
case_images: 10.1177_2050313X241235444-fig5.jpg
case_images: PMC10960974_01_10.1177_2050313X241235444-fig5.jpg
case_images: fig5-2050313X241235444
case_images: Right axilla.. Left: Prior to treatment with Baricitinib. Right: 4 weeks after discontinuing Baricitinib (12 weeks completed).
case_images: 10.1177_2050313X241235444-fig6.jpg
case_images: PMC10960974_01_10.1177_2050313X241235444-fig6.jpg
case_images: fig6-2050313X241235444
case_images: Moreover, the ulcers on her right axilla (Figure A6) and right elbow (Figure A4) had also increased in size over this time, and demonstrated perilesional erythema. The ulcers on the right axilla (Figure A6) and right elbow (Figure A4) resolved.
case_images: Right axilla.. Right: 13 weeks after discontinuing Baricitinib.
case_images: 10.1177_2050313X241235444-fig7.jpg
case_images: PMC10960974_01_10.1177_2050313X241235444-fig7.jpg
case_images: fig7-2050313X241235444